➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
McKinsey
Baxter
AstraZeneca
Harvard Business School

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DESLORATADINE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Desloratadine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00160537 POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) Completed UCB Pharma Phase 4 2005-05-01 Comparative study on clinical efficacy and safety of levocetirizine and desloratadine as measured by the subject's satisfaction/dissatisfaction after one week of treatment
NCT00160589 LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis) Completed UCB Pharma Phase 4 2005-04-01 Two weeks study to evaluate the efficacy and safety of Levocetirizine and Desloratadine in patients suffering from Allergic Rhinitis (AR)
NCT00264303 CUTE (Chronic Urticaria Treatment Evaluation) Completed UCB Pharma Phase 4 2005-12-01 A study to compare the clinical efficacy and safety of Levocetirizine vs. Desloratadine in patients suffering from Chronic Idiopathic Urticaria (CIU) measured by the mean pruritus severity score over the first week of treatment
NCT00311844 A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) Completed Merck Sharp & Dohme Corp. Phase 4 2005-03-01 This study was a double-blind, placebo-controlled, cross-over, single-center study of desloratadine 5 mg or placebo in subjects 18 years of age or older with a history of seasonal allergic rhinoconjunctivitis. This study was performed to examine the effects of desloratadine compared with placebo, on the signs and symptoms of allergic conjunctivitis induced by direct conjunctival challenges with a previously identified sensitizing antigen, in the eyes of a subject known to be sensitive to the antigen.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Desloratadine

Condition Name

Condition Name for Desloratadine
Intervention Trials
Urticaria 10
Seasonal Allergic Rhinitis 9
Allergic Rhinitis 9
Chronic Idiopathic Urticaria 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Desloratadine
Intervention Trials
Rhinitis 26
Rhinitis, Allergic 25
Urticaria 17
Rhinitis, Allergic, Seasonal 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Desloratadine

Trials by Country

Trials by Country for Desloratadine
Location Trials
United States 8
Germany 6
Brazil 5
Canada 3
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Desloratadine
Location Trials
Florida 5
New Jersey 2
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Desloratadine

Clinical Trial Phase

Clinical Trial Phase for Desloratadine
Clinical Trial Phase Trials
Phase 4 25
Phase 3 21
Phase 2/Phase 3 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Desloratadine
Clinical Trial Phase Trials
Completed 53
Recruiting 4
Unknown status 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Desloratadine

Sponsor Name

Sponsor Name for Desloratadine
Sponsor Trials
Merck Sharp & Dohme Corp. 31
Dr. Reddy's Laboratories Limited 6
UCB Pharma 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Desloratadine
Sponsor Trials
Industry 53
Other 12
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
McKesson
Johnson and Johnson
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.